Physician profile
Scott Rubinstein
NPI 1154374809
$1,410.59
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $661 · 2021: $155.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $500.00 | 2020 | |
| US Implant Solutions, LLC | $265.78 | 2019 | |
| Pacira Therapeutics, INC. | $224.94 | 2019-2021 | |
| Electronic Waveform Lab, INC. | $190.00 | 2019 | |
| Depuy Synthes Sales INC. | $112.96 | 2021 | |
| Sanofi-Aventis U.S. LLC | $27.11 | 2020 | |
| Horizon Therapeutics Plc | $23.76 | 2019 | |
| Kci USA, INC. | $19.75 | 2019 | |
| Convatec INC. | $17.35 | 2019 | |
| Ermi LLC | $15.84 | 2020 | |
| Axogen | $13.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.